BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25271628)

  • 1. TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen.
    Tsuji S; Stein L; Kamada N; Nuñez G; Bram R; Vallance BA; Sousa AE; Platt JL; Cascalho M
    J Clin Invest; 2014 Nov; 124(11):4857-66. PubMed ID: 25271628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.
    Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS
    Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
    Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
    Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
    J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
    Banday VS; Thyagarajan R; Sundström M; Lejon K
    Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival.
    Ou X; Xu S; Lam KP
    Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15401-6. PubMed ID: 22949644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA.
    Platt JL; de Mattos Barbosa MG; Huynh D; Lefferts AR; Katta J; Kharas C; Freddolino P; Bassis CM; Wobus C; Geha R; Bram R; Nunez G; Kamada N; Cascalho M
    JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34111031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
    Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
    J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TACI Contributes to
    Parra M; Yang J; Weitner M; Derrick S; Yang A; Schmidt T; Singh B; Moreno A; Akkoyunlu M
    Front Immunol; 2018; 9():2612. PubMed ID: 30473702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.
    Jabara HH; Lee JJ; Janssen E; Ullas S; Liadaki K; Garibyan L; Benson H; Sannikova T; Bram R; Hammarstrom L; Cruz AC; Siegel R; Manis J; Malley R; Geha RS
    J Allergy Clin Immunol; 2017 Apr; 139(4):1293-1301.e4. PubMed ID: 27609654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow.
    Tsuji S; Cortesão C; Bram RJ; Platt JL; Cascalho M
    Blood; 2011 Nov; 118(22):5832-9. PubMed ID: 21984806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
    Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
    J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells.
    Smulski CR; Zhang L; Burek M; Teixidó Rubio A; Briem JS; Sica MP; Sevdali E; Vigolo M; Willen L; Odermatt P; Istanbullu D; Herr S; Cavallari M; Hess H; Rizzi M; Eibel H; Schneider P
    Cell Rep; 2022 Mar; 38(13):110583. PubMed ID: 35354034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8.
    Waldrep ML; Zhuang Y; Schroeder HW
    BMC Med Genet; 2009 Sep; 10():100. PubMed ID: 19775471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.
    Allman WR; Dey R; Liu L; Siddiqui S; Coleman AS; Bhattacharya P; Yano M; Uslu K; Takeda K; Nakhasi HL; Akkoyunlu M
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4094-103. PubMed ID: 26170307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
    Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
    J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TACI, isotype switching, CVID and IgAD.
    Castigli E; Geha RS
    Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACI deficiency - a complex system out of balance.
    Salzer U; Grimbacher B
    Curr Opin Immunol; 2021 Aug; 71():81-88. PubMed ID: 34247095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
    Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.